Please login to the form below

Not currently logged in
Email:
Password:

Lilly invests $700m in insulin manufacturing

Expands plants in Puerto Rico, France, China and US
Eli Lilly HQ

Lilly is to invest $700m to expand its insulin manufacturing capabilities across the world to address rising numbers of people with diabetes.

The pharma company, which manufactures the Humalog family of insulins, will expand operations in Puerto Rico, France and China, as well as its hometown of Indianapolis in the US.

The investment adds to a previous commitment of $180m for Lilly's US operations, bringing the company's total investment in insulin manufacturing during 2013 to just under $1bn.

Lilly is counting on the increasing global prevalence of diabetes driving demand for insulin, which is used to reduce blood sugar levels in people with both type 1 and type 2 diabetes.

This predicted increase in diabetes levels was confirmed yesterday on World Diabetes Day by the International Diabetes Federation (IDF), which published a revised Diabetes Atlas that forecasts that the number of people living with diabetes will increase from 382 million to 592 million by 2035.

One of the worst hit countries is set to be China, due in part to the influx of Western diets and more sedentary lifestyles.

Of the $700m funding, Lilly's China operations will receive $350m to expand insulin cartridge manufacturing capacity, adding to the recent opening of the Lilly China Research and Development Center in Shanghai last year.

Jacques Tapiero, senior VP and president of Lilly Emerging Markets, said: “Our ongoing investment in China will help Lilly bring medicines to the country with the largest population of people with diabetes - and which is projected to rise to more than 142 million by 2035."

Outside China the company has earmarked $245m to expand insulin-active-ingredient and delivery device manufacturing capacity in both Indianapolis and Puerto Rico and some $100m to enhance its insulin cartridge manufacturing capacity in France.

Article by
Thomas Meek

15th November 2013

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

If you needed an organ transplant, would you have one?
Lauren Packer discusses the worsening problem in the UK with an imbalance between the number of organs needed, and the number of those being donated....
Why tugging at our heartstrings is no longer enough to make us open our purses
Charlotte Shyllon (Director and Partner) and Maren Thurow (Senior Account Executive), discuss the highly emotive Make a Child Cry campaign video from Doctors of the World (Médecins du Monde)....
quantify_messages.png
Exploring full potential of e-detailing data
Today’s high quality e-detailing data can create better quality conversations with healthcare professionals and result in improved access and relationships....

Infographics